AstraZeneca PLC (AZN)

AstraZeneca Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	215,990	203,171	209,268	209,442	182,034	131,259
Market Cap Growth	7.85%	-2.91%	-0.08%	15.06%	38.68%	-0.69%
Enterprise Value	244,062	228,175	234,801	238,391	209,520	149,836
Last Close Price	70.07	64.61	65.04	64.15	53.86	45.01
PE Ratio	27.79	28.88	35.14	63.70	1625.31	41.07
PS Ratio	3.93	3.76	4.57	4.72	4.87	4.93
PB Ratio	5.25	4.97	5.34	5.65	4.63	8.39
P/FCF Ratio	19.37	20.45	23.29	24.03	37.36	34.20
P/OCF Ratio	16.50	17.13	20.23	21.35	30.53	27.35
EV/Sales Ratio	4.44	4.22	5.13	5.38	5.60	5.63
EV/EBITDA Ratio	13.35	12.99	16.51	17.35	31.27	21.44
EV/EBIT Ratio	17.93	17.65	24.34	27.05	72.32	34.29
EV/FCF Ratio	21.89	22.96	26.14	27.35	43.01	39.04
Debt / Equity Ratio	0.77	0.75	0.76	0.84	0.85	1.45
Debt / EBITDA Ratio	1.70	1.70	2.04	2.23	4.81	3.15
Debt / FCF Ratio	2.84	3.07	3.30	3.57	6.85	5.92
Asset Turnover	0.53	0.53	0.46	0.44	0.44	0.42
Inventory Turnover	1.72	1.80	1.59	1.26	1.85	1.45
Quick Ratio	0.69	0.67	0.58	0.62	0.67	0.67
Current Ratio	0.90	0.93	0.82	0.86	1.16	0.96
Return on Equity (ROE)	19.79%	17.59%	15.64%	8.63%	0.42%	20.80%
Return on Assets (ROA)	8.16%	7.88%	6.10%	5.46%	2.10%	4.26%
Return on Capital (ROIC)	11.73%	11.53%	8.80%	7.82%	3.26%	7.45%
Return on Capital Employed (ROCE)	17.60%	17.00%	13.70%	12.60%	3.50%	9.40%
Earnings Yield	3.60%	3.46%	2.85%	1.57%	0.06%	2.44%
FCF Yield	5.16%	4.89%	4.29%	4.16%	2.68%	2.92%
Dividend Yield	2.17%	4.80%	4.46%	4.52%	5.33%	6.22%
Payout Ratio	30.59%	65.80%	75.25%	132.72%	3442.86%	111.77%
Buyback Yield / Dilution	-0.08%	-0.06%	-0.13%	-9.32%	-8.68%	-0.92%
Total Shareholder Return	2.09%	4.73%	4.33%	-4.80%	-3.35%	5.30%

Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q